RC RANDOM CHAOS

Shkreli accused of violating pharma ban through stock trades and livestreams

· via Ars Technica

Original source

Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says

Ars Technica →

Martin Shkreli, the former pharmaceutical executive known for a 4,000 percent price hike on a drug, has been under a lifetime ban from the industry since 2022. The FTC and seven states allege he has repeatedly violated this ban by trading stock in drug companies and discussing the industry on livestreams. They are seeking a court order to hold him in contempt, force him to divest from pharmaceutical companies, and pay fines equal to his profits from these trades. The ban, imposed due to Shkreli’s past illegal conduct, explicitly prohibits stock ownership and public statements that could influence pharmaceutical businesses. The FTC and states also want the court to establish clear consequences for future violations, including financial penalties and potential incarceration.

Read the full article

Continue reading at Ars Technica →

This is an AI-generated summary. Read the original for the full story.